Next Generation News and Research

RSS

ConforMIS' iUni G2 patient-specific knee replacement system receives CE Mark certification

ConforMIS, Inc. announced today that the iUni® G2 has received CE Mark certification, providing regulatory approval for ConforMIS to begin the sale of this products throughout the European Union. The iUni G2 is the next generation of ConforMIS' revolutionary patient-specific knee replacement system, and remains the only patient-specific unicompartmental knee resurfacing implant on the market.

15 Apr 2010

Trevena commences Phase I trial of TRV120027 biased ligand for acute decompensated heart failure

Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced the initiation of a Phase I clinical trial of TRV120027, a titratable i.v. agent designed for the treatment of acute decompensated heart failure. TRV120027 is a biased ligand that targets the angiotensin II type 1 receptor (AT1R) and induces a unique mode of signaling.

15 Apr 2010

Valuable resource for surgeons published

Key Topics in Surgical Research and Methodology represents a comprehensive reference text accessible to the surgeon embarking on an academic career. Four key elements are covered: Surgical Research, Research Methodology, Practical Problems and Solutions on Research as well as Recent Developments and Future Prospects in Surgical Research and Practice.

13 Apr 2010

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

A strategic alliance announced today between TGen Drug Development (TD2) and Horizon Discovery Limited will significant advance personalized medicine.

13 Apr 2010

The EMBO Meeting 2010: Over 120 researchers to present

More than 120 leading researchers from across the molecular life sciences will speak at The EMBO Meeting 2010 - the second annual life sciences conference to be organized by the European Molecular Biology Organization (EMBO) and held in Barcelona from 4 - 7 September 2010.

13 Apr 2010

Genzyme, Arecor establish strategic partnership for developing advanced protein therapeutic formulations

Genzyme Corporation and Arecor Limited today signed an agreement providing for extensive collaboration on developing advanced formulations for protein therapeutics. The agreement provides for a close working relationship between Genzyme and Arecor in developing stable, high strength formulations of labile biomolecules. This agreement is the result of a two year working relationship where Arecor has demonstrated their technologies offer an improvement over conventional approaches in protein formulation.

13 Apr 2010

Stem cell scientists receive stimulus grants to study lung and blood disorders

Stem cell scientists at The University of Texas Health Science Center at Houston (UTHealth) were awarded stimulus grants totaling almost $2 million to research experimental treatments for blood disorders and inherited lung diseases affecting children.

13 Apr 2010

Verizon Wireless, BL Healthcare to jointly trial solutions for delivery of remote healthcare applications

Verizon Wireless today announced an initiative with BL Healthcare and a number of customers and third-party providers to jointly trial next-generation solutions for the delivery of remote healthcare applications and services to patients. This initiative will provide a unique approach for addressing issues associated with access to quality healthcare and rising healthcare costs.

12 Apr 2010

Statement shows key links between healthy communities and physical structure of buildings, cities

An international education network led by the University of the West of England has issued a statement relating to the key links between healthy communities and the physical structure of buildings and cities.

12 Apr 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102, the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease, April 10 to 13, 2010, in Vienna Austria.

12 Apr 2010

Clarian Health Partners selects MedVentive as technology partner

Clarian Health Partners, Indiana's largest healthcare system, has selected MedVentive as a technology partner for its clinically-integrated network, Clarian Quality Partners.

9 Apr 2010

LensAR receives patent for using laser technology to increase flexibility of ocular lens

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced the issuance of United States patent 7,655,002. This patent addresses methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

8 Apr 2010

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Cempra Pharmaceuticals today announced its schedule of poster presentations at the 20th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna, Austria, on April 10-13, 2010.

8 Apr 2010

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid will initiate European launch of its newest addition to the GeneXpert® family of molecular diagnostic testing systems, the GeneXpert Infinity-48, at the 20th annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Vienna, Austria. The GeneXpert Infinity-48 System is the world's first and only fully-automated, random-access system designed for management of the entire molecular testing workflow — from sample data, cartridge loading and unloading, to final reporting of test results and disposal of cartridges.

7 Apr 2010

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

7 Apr 2010

Thomson Reuters ranks UC San Diego Health System as one of nation's top 15 major teaching hospitals

UC San Diego Health System was recently listed as one the nation's top 15 major teaching hospitals by Thomson Reuters, a leading provider of information and solutions to improve the cost and quality of health care. The award recognizes hospitals that have achieved excellence in clinical outcomes, patient safety, patient satisfaction, financial performance, and operational efficiency. This is first time UC San Diego Health System has been recognized with this honor.

7 Apr 2010

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

Sigma-Aldrich® announced today that it has signed an agreement with New Mexico Highlands University through its licensee, Highlands Stable Isotope Corp., to exclusively distribute a novel set of patented stable isotope labeled synthetic reagents.

7 Apr 2010

Global Summit on Nurse Faculty Migration to identify solutions for shortage of nurse faculty

The global nursing shortage is due in part to a lack of faculty in nursing schools and to a phenomenon known as nurse migration, where nurses leave their country of origin to work elsewhere. In response, the International Council of Nurses and the Honor Society of Nursing, Sigma Theta Tau International, supported by The Elsevier Foundation, will conduct the Global Summit on Nurse Faculty Migration-a meeting of nurse experts who will examine the problem, and identify realistic and measurable solutions.

7 Apr 2010

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis. Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

6 Apr 2010

$DFine brings advance access system for treating vertebral compression fractures$

DFine brings advance access system for treating vertebral compression fractures

DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures, announced today that it has launched a next generation access system for the RF Kyphoplasty procedure using the StabiliT® Vertebral Augmentation System.

6 Apr 2010

Next Generation News and Research

ConforMIS' iUni G2 patient-specific knee replacement system receives CE Mark certification

Trevena commences Phase I trial of TRV120027 biased ligand for acute decompensated heart failure

Valuable resource for surgeons published

TD2, Horizon Discovery announce strategic alliance to advance personalized medicine

The EMBO Meeting 2010: Over 120 researchers to present

Genzyme, Arecor establish strategic partnership for developing advanced protein therapeutic formulations

Stem cell scientists receive stimulus grants to study lung and blood disorders

Verizon Wireless, BL Healthcare to jointly trial solutions for delivery of remote healthcare applications

Statement shows key links between healthy communities and physical structure of buildings, cities

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Clarian Health Partners selects MedVentive as technology partner

LensAR receives patent for using laser technology to increase flexibility of ocular lens

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Thomson Reuters ranks UC San Diego Health System as one of nation's top 15 major teaching hospitals

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

Global Summit on Nurse Faculty Migration to identify solutions for shortage of nurse faculty

New study shows utility of Chronix Biomedical's serum DNA tests in MS

DFine brings advance access system for treating vertebral compression fractures

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News